- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03840382
Telemedicine for PrEP Throughout Mississippi (Tele-PrEP)
Study Overview
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Larry K Brown, MD
- Phone Number: (401)-793-8808
- Email: lkbrown@lifespan.org
Study Contact Backup
- Name: James B Brock, MD
- Phone Number: (601) 984-5560
- Email: jbbrock@umc.edu
Study Locations
-
-
Mississippi
-
Jackson, Mississippi, United States, 39216
- Recruiting
- University of Mississippi Medical Center
-
Contact:
- James B Brock, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 18 years old or older
- Presented at a collaborating CBO for HIV testing during trial months
- PrEP eligible based on HIV Risk Checklist
- Able to read and speak English
- Able to give meaningful consent as determined by research staff
- No known HIV infection
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Tele-PrEP Intervention
The telemedicine intervention will allow participants to discuss HIV prevention and PrEP with PrEP specialists at an academic medical center via videoconference from their local community based organization (CBO).
During the intervention, participants will gain information related to HIV and PrEP, view a video to improve motivation for engagement in PrEP related care, and receive resources to address barriers to care.
|
Telemedicine conferences with PrEP-specialists
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Appointment attendance at 3 months post-intervention (electronic medical record extraction)
Time Frame: Assessed at 3 months
|
Attendance at a telemedicine for PrEP appointment with a UMMC PrEP specialist, in the past 3 months, extracted from patient's electronic medical record
|
Assessed at 3 months
|
Appointment attendance at 6 months post-intervention (electronic medical record extraction)
Time Frame: Assessed at 6 months
|
Attendance at a telemedicine for PrEP appointment with a UMMC PrEP specialist, in the past 3 months, extracted from patient's electronic medical record
|
Assessed at 6 months
|
Receipt of PrEP medication prescription at 3 months (electronic medical record extraction)
Time Frame: Assessed at 3 months
|
PrEP medication was prescribed in past 3 months, extracted for patient's electronic medical record
|
Assessed at 3 months
|
Receipt of PrEP medication prescription at 6 months (electronic medical record extraction)
Time Frame: Assessed at 6 months
|
PrEP medication was prescribed in past 3 months, extracted for patient's electronic medical record
|
Assessed at 6 months
|
Change in adherence to PrEP (self-report)
Time Frame: Assessed at 3 months and 6 months
|
Self-reported proportion of PrEP doses taken in past 3 months.
(Change in adherence = self-reported adherence at 6 months - self-reported adherence at 3 months)
|
Assessed at 3 months and 6 months
|
Number of PrEP medication refills at 3 months (electronic medical record extraction)
Time Frame: Assessed at 3 months
|
Number of PrEP refills in past 3 months (extracted from electronic medical record)
|
Assessed at 3 months
|
Number of PrEP medication refills at 6 months (electronic medical record extraction)
Time Frame: Assessed at 6 months
|
Number of PrEP refills in past 3 months (extracted from electronic medical record)
|
Assessed at 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
PrEP knowledge
Time Frame: Assessed at Baseline, 3 months, and 6 months
|
15-item questionnaire to assess knowledge (true/false/don't know) based on facts from the CDC and the San Francisco AIDS Foundation websites concerning PrEP
|
Assessed at Baseline, 3 months, and 6 months
|
Motivational readiness for PrEP and PrEP-related care
Time Frame: Assessed at Baseline, 3 months, and 6 months
|
Rollnick, S., Heather, N., Gold, R., Hall, W., 1992. Development of a short 'readiness to change' questionnaire for use in brief, opportunistic interventions among excessive drinkers. Br J Addict. 87, 743-754. Rollnick's Readiness Ruler will be used to assess motivation for engaging in PrEP care using two items from 1 (not ready) to 10 (ready to engage). |
Assessed at Baseline, 3 months, and 6 months
|
Intervention acceptability (SEF)
Time Frame: Assessed at 3 months and 6 months
|
Kennard, B., Brown, L., Hawkins, L., Risi, A., Radcliffe, J., Emslie, G. (2014). Development and implementation of health and wellness CBT for individuals with depression and HIV. Cogn Behav Pract. 21(2): 237-246. The Acceptability of Tele-PrEP by clients, CBO staff, administrators and UMMC physicians will be assessed with a modified version of the Session Evaluation Form (SEF). |
Assessed at 3 months and 6 months
|
Intervention acceptability (CSQ-8)
Time Frame: Assessed at 3 months and 6 months
|
Larsen, D.L., Attkisson, C.C., Hargreaves, W.A., Nguyen, T.D. Assessment of client/patient satisfaction: Development of a general scale, Evaluation and Program Planning. 1979; 2, 197-207. The Acceptability of Tele-PrEP by clients, CBO staff, administrators and UMMC physicians will be assessed with a modified version of the Client Satisfaction Questionnaire (CSQ-8). |
Assessed at 3 months and 6 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Larry K Brown, MD, Rhode Island Hospital
- Principal Investigator: James B Brock, MD, University of Mississippi Medical Center
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- RNA Virus Infections
- Virus Diseases
- Infections
- Blood-Borne Infections
- Communicable Diseases
- Sexually Transmitted Diseases, Viral
- Sexually Transmitted Diseases
- Lentivirus Infections
- Retroviridae Infections
- Immunologic Deficiency Syndromes
- Immune System Diseases
- Slow Virus Diseases
- HIV Infections
- Acquired Immunodeficiency Syndrome
Other Study ID Numbers
- 407618
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV/AIDS
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
University of California, San DiegoNational Institute of Allergy and Infectious Diseases (NIAID)Completed
-
University of Massachusetts, BostonCompleted
-
Stanford UniversityJanssen Services, LLCCompleted
-
ViiV HealthcareJohns Hopkins University; Pfizer; Vanderbilt University; University of North Carolina...Completed
-
Medical College of WisconsinCompleted
-
Emory UniversityCompleted
-
Rhode Island HospitalUnknown
-
Tibotec Pharmaceuticals, IrelandCompleted
-
Lampiris, Harry W., M.D.AbbottUnknown
Clinical Trials on Tele-PrEP Intervention
-
University of California, San FranciscoNational Institute of Nursing Research (NINR); San Francisco Department of...CompletedHIV/AIDSUnited States
-
University of ChicagoUniversity of Athens; National Development and Research Institutes, Inc.Completed
-
Samsung Medical CenterRecruitingChronic Obstructive Pulmonary DiseaseKorea, Republic of
-
Rigshospitalet, DenmarkCompletedCOVID | Posttraumatic Stress Disorder | Prolonged Grief DisorderDenmark
-
University of Wisconsin, MadisonVirginia Commonwealth UniversityRecruitingDevelopmental DisabilityUnited States
-
University of North Carolina, Chapel HillNational Institute of Allergy and Infectious Diseases (NIAID)RecruitingHIV Pre-Exposure ProphylaxisUnited States
-
Northwestern UniversityEmory UniversityActive, not recruitingPrimary Progressive Aphasia | Caregiver BurnoutUnited States
-
Emory UniversityNational Institute of Mental Health (NIMH)Recruiting
-
Montefiore Medical CenterNational Institute of Mental Health (NIMH); Albert Einstein College of Medicine and other collaboratorsCompletedHIV Prevention | PrEP UptakeUnited States